Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-05

FDA Approved: CHLORZOXAZONE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for chlorzoxazone (a generic muscle relaxant) from Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorzoxazone (Chlorzoxazone)

Snippet

ORIG AP for CHLORZOXAZONE (CHLORZOXAZONE)